(anoniem) Help for your cholesterol when statins won't do. If you are one of the many, but also one of the few... Harv Mens Health Watch. 2005 Mar;9(8):1-4

Altschul R, Hoffer A, Stephen JD. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem. 1955;54:558–569

Asztalos BF. High-density lipoprotein particles, coronary heart disease, and niacin. Journal of Clinical Lipidology (2010) 4, 405–410

Bermúdez V, Arráiz N et al. Lipoprotein(a): from molecules to therapeutics. Am J Ther. 2010 May-Jun;17(3):263-73

Bots M, Visseren FL et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007; 370: 153-60

Cesar TB, Aptekmann NP et al. Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects. Nutr Res. 2010 Oct;30(10):689-94

Culberson A, Kafai MR et al. Glycemic load is associated with HDL cholesterol but not with the other components and prevalence of metabolic syndrome in the third National Health and Nutrition Examination Survey, 1988-1994. Int Arch Med. 2009 Jan 13;2(1):3

Davidson MH. Apolipoprotein measurements: is more widespread use clinically indicated? Clin Cardiol. 2009 Sep;32(9):482-6.

Federaal Kenniscentrum voor de Gezondheidszorg. Gebruik cholesterolverlagers (statines) laatste 12 jaar vertwintigvoudigd (04/11/2010). http://www.kce.fgov.be/index_nl.aspx?SGREF=5283&CREF=18220

Ferenczi EA, Asaria P et al. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? Am J Cardiol. 2010 Aug 15;106(4):587-92.

Gangwisch JE, Malaspina D et al. Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health. Sleep. 2010 Jul 1;33(7):956-61

Grundy SM, Vega GL et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med. 2002 Jul 22;162(14):1568-76

Jacobson TA. A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clin Proc. 2010 Apr;85(4):365-79

Keener A, Sanossian N. Niacin for stroke prevention: evidence and rationale. CNS Neuroscience & Therapeutics; 2008; 14:287-294

Keidar S, Guttmann H et al. High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1192-4.

Kelley GA, Kelley KS et al. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2004 Dec;13(10):1148-64

Kim SY, Yoon S et al. Kale juice improves coronary artery disease risk factors in hypercholesterolemic men. Biomed Environ Sci. 2008 Apr;21(2):91-7

Lehto SM, Niskanen L et al. Low serum HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder. Psychiatry Clin Neurosci. 2010 Jun;64(3):279-83. Epub 2010 Mar 30.

Liu J, Sempos CT et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol. 2006 Nov 15;98(10):1363-8. Epub 2006 Sep 29

Mymin D, Dembinski T et al. Iatrogenic severe depression of high-density lipoprotein cholesterol. J Clin Pharmacol. 2009 Jul;49(7):865-71. Epub 2009 Apr 29.

Nago N, Ishikawa S et al. Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. J Epidemiol. 2011;21(1):67-74. Epub 2010 Dec 11

Nakashima M, Sakurai M et al. Dietary glycemic index, glycemic load and blood lipid levels in middle-aged Japanese men and women. J Atheroscler Thromb. 2010 Oct 27;17(10):1082-95. Epub 2010 Jul 30.

Olsson AG. HDL and LDL as therapeutic targets for cardiovascular disease prevention: The possible role of niacin. Nutrition, Metabolism & Cardiovascular Diseases (2010) 20, 553-557

Qin Y, Xia M et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr 2009;90:485-92

Qing Yu, Xia M et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr 2009;90:485-92

Raal FJ. Questioning the importance of LDL cholesterol don't throw the baby out with the bathwater! Cardiovascular journal of africa Vol 19, No. 2, March/April 2008

Roza JM, Xian-Liu Z et al. Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects. Altern Ther Health Med. 2007 Nov-Dec;13(6):44-8

Sagud M, Mihaljevic-Peles A et al. Lipid levels in female patients with affective disorders. Psychiatry Res. 2009 Aug 15;168(3):218-21. Epub 2009 Jun 27.

Shargorodsky M, Debby O et al. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond). 2010 Jul 6;7:55

Sutin AR, Terracciano A et al. Cholesterol, triglycerides, and the Five-Factor Model of personality. Biol Psychol. 2010 May;84(2):186-91. Epub 2010 Jan 28.

Vosper H. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol. 2009 September; 158(2): 429–441

Wierzbicki AS. Fibrates: no ACCORD on their use in the treatment of dyslipidaemia. Curr Opin Lipidol. 2010 Aug;21(4):352-8